Lusaris Therapeutics
Morrisville, US · Founded 2021
Biotech
Founders & leadership
RF
Ramin Farzaneh-FarExecutive Officer
AL
Andrew LevinExecutive Officer, Director
CR
Catherine RiesenExecutive Officer
DG
Daniel GrauDirector
EM
Edward MonaghanExecutive Officer, Director, Promoter
NB
Neil BuckleyExecutive Officer
Reported raises · per SEC filings
Form D private placements▶$60.2MraisedDec 2022 · 9 investors · PharmaceuticalsRule 506(b)
▶$60.2MraisedDec 2022 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ramin Farzaneh-FarExecutive Officer
- Andrew LevinExecutive Officer, Director
- Catherine RiesenExecutive Officer
- Daniel GrauDirector
- Edward MonaghanExecutive Officer, Director, Promoter
- Neil BuckleyExecutive Officer
- Offering amount
- $60.2M
- Amount sold
- $60.2M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.